EP1653932A1 — Modified release compositions for minocycline
Assigned to Ranbaxy Laboratories Ltd · Expires 2006-05-10 · 20y expired
What this patent protects
The technical field of the present invention relates to nonspheronized multiparticulate modified release compositions of 7-dimethylamino-6-deoxy-6-demethyltetracycline (minocycline) or non-toxic acid addition salts thereof. In particular, the present invention relates to a modifi…
USPTO Abstract
The technical field of the present invention relates to nonspheronized multiparticulate modified release compositions of 7-dimethylamino-6-deoxy-6-demethyltetracycline (minocycline) or non-toxic acid addition salts thereof. In particular, the present invention relates to a modified release compositions that deliver minocycline in a pulsatile manner over a prolonged period and processes for their preparation.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.